{"id":"W6977161993","doi":"10.6084/m9.figshare.24070298","title":"Additional file 1 of Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Placebo; Adverse effect; Overall survival; Postmenopausal women; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005803458,0.0003063903,0.0005395414,0.00009408813,0.00009497186,0.0000197426,0.0002503636,0.0001135658,0.9522986],"category_scores_gemma":[0.0005049095,0.0002205898,0.00006593675,0.000662937,0.00004747878,0.0002267276,0.00009441757,0.0003787731,0.0003167141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004346702,"about_ca_system_score_gemma":0.0006127187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002168748,"about_ca_topic_score_gemma":0.0009034132,"domain_scores_codex":[0.9979492,0.00006784769,0.0004184999,0.0004583749,0.0005785486,0.0005274912],"domain_scores_gemma":[0.9972401,0.001731524,0.0002773528,0.0003831771,0.0002231888,0.0001446598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05843445,0.0001895528,0.0000919425,0.0001171836,0.0003278358,0.0001434573,0.0007596309,0.002403978,0.0002119924,0.000001656926,0.9271342,0.01018419],"study_design_scores_gemma":[0.05690001,0.001247528,0.4058987,0.01152522,0.00004738799,0.00006025706,0.0007929148,0.0006597065,0.0001026372,0.0001889312,0.5219378,0.0006388892],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.05885278,0.0001033391,3.344523e-7,0.0008657065,0.00007224761,0.0007795979,0.939013,0.0001375999,0.0001754062],"genre_scores_gemma":[0.06769835,0.0000170316,0.0002093513,0.0003599943,0.0006846609,0.004135394,0.9259577,0.00008675973,0.0008507933],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.9519819,"threshold_uncertainty_score":0.8995389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02565653570190988,"score_gpt":0.2702826857817846,"score_spread":0.2446261500798747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}